Skip to search formSkip to main contentSkip to account menu

NZ 105

Known as: NZ-105 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
We previously reported that efonidipine hydrochloride, a new long-acting calcium antagonist, prevented the progression of… 
1994
1994
We investigated the effects of a newly synthesized dihydropyridine (DHP) derivative (NZ-105) on intracellular Ca transients and… 
1992
1992
Summary: The effects of a new dihydropyridine derivative, NZ-105, on renal function were investigated in anesthetized… 
1991
1991
The vasorelaxing and dihydropyridine receptor binding properties of NZ-105, a new dihydropyridine derivative, were studied using… 
1991
1991
The correlation between the binding of NZ-105, a newly synthesized 1,4-dihydropyridine (DHP) derivative, on DHP receptors and its… 
1991
1991
SummaryThe inhibitory effect of a new dihydropyridine derivative, (±)-2-[benzyl(phenyl)amino]ethyl-1,4-dihydro-2,6-dimethyl-5-(5… 
1991
1991
The cardiovascular selectivity of NZ-105, a novel dihydropyridine derivative, was studied in vitro in comparison with nicardipine… 
1990
1990
Studies on the antihypertensive and diuretic actions of NZ-105, a new dihydropyridine derivative, were performed in comparison…